IP Library › Assignment 040531/0005
Patent Assignment
Reel/Frame 040531/0005

Change of Name

Recorded: 2016-12-05 Pages: 2
Assignor
Assignee
ARBUTUS BIOPHARMA CORPORATION
100-8900 GLENLYON PARKWAY, BURNABY, BRITISH COLUMBIA, V5J 5J8, CANADA
Covered Properties (2)
Methods For Increasing Efficacy of Lipid Formulated siRNA
Patent: 9,051,567 →
Application: 13/378,346 →
Publication: US 2012/0244207
METHODS FOR INCREASING EFFICACY OF LIPID FORMULATED siRNA
Application: 14/700,938 →
Publication: US 2016/0024498
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 1, 2012
From: FITZGERALD, KEVIN; FRANK-KAMENETSKY, MARIA; AKINC, AKIN; MAIER, MARTIN A.
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 028139/0261 →
Assignment of Assignor's Interest Dec 5, 2016
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 040531/0036 →
Assignment of Assignor's Interest Dec 5, 2016
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 040531/0055 →
Assignment of Assignor's Interest Dec 5, 2016
From: FITZGERALD, KEVIN; AKINC, AKIN; MAIER, MARTIN A.; FRANK-KAMENETSKY, MARIA
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 040819/0004 →
Merger and Change of Name Jun 21, 2018
From: PROTIVA BIOTHERAPEUTICS INC.; ARBUTUS BIOPHARMA CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 046406/0881 →
Merger and Change of Name Jul 27, 2018
From: PROTIVA BIOTHERAPEUTICS INC.; ARBUTUS BIOPHARMA CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 046640/0764 →